pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Quality assessment of the studies included in the meta-analysis

Cohort study Selection Comparability Outcome Total



Representativeness of the exposed cohort Selection of the non-exposed cohort Ascertainment of exposure Demonstration that outcome of interest was not present at start of study Assessment of outcome Length of follow-up Adequacy of follow-up cohorts
Jasper Seth Yao et al. 2020 * * * * ** * - * 8
Jennifer A Frontera et al. 2020 * * * * * * * * 8
Philip M Carlucci et al. 2020 * * * * ** * * * 9
Randomized controlled study Selection bias Performance bias Detection bias Attrition bias Reporting bias Other bias
Random sequence generation Allocation concealment Blinding (performance) Blinding (detection) Incomplete outcome data Selective reporting Other sources of bias
Sherief Abd-Elsalam et al. 2020 unclear unclear unclear unclear low low low unclear

* 1 point, **2 point

Korean J Clin Pharm 2021;31:136-44 https://doi.org/10.24304/kjcp.2021.31.2.136
© 2021 Korean J Clin Pharm